Clinical Trials Directory

Trials / Conditions / Lupus Erythematosus, Cutaneous

Lupus Erythematosus, Cutaneous

15 registered clinical trials studyying Lupus Erythematosus, Cutaneous.

StatusTrialSponsorPhase
TerminatedA Study to Learn About the Study Medicine (PF-06823859) in Adults With Active CLE or SLE With Skin Symptoms.
NCT05879718
PfizerPhase 2
WithdrawnEfficacy of Fractional Er:YAG Laser in Lupus Erythematosus Scars
NCT04707924
Insel Gruppe AG, University Hospital BernN/A
CompletedA Study to Assess the Safety and Drug Levels of BMS-986256 in Participants With Active Cutaneous Lupus Erythem
NCT04493541
Bristol-Myers SquibbPhase 1
CompletedSafety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effect of GSK2646264 in Cutaneous Lupus
NCT02927457
GlaxoSmithKlinePhase 1
CompletedTargeted Therapy Using Intradermal Injection of Etanercept for Remission Induction in Discoid Lupus Erythemato
NCT02656082
University of LeedsPhase 2
TerminatedAutologous Polyclonal Tregs for Lupus
NCT02428309
National Institute of Allergy and Infectious Diseases (NIAID)Phase 1
TerminatedRole of Proteasomes in a Dermatological Autoimmune Disease: Bullous Pemphigoid
NCT01559155
Centre Hospitalier Universitaire de Nīmes—
CompletedA Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy V
NCT02034344
Janssen Research & Development, LLC—
CompletedA Non-drug Study Profiling Cutaneous Lupus
NCT01923415
Janssen Research & Development, LLC—
TerminatedEfficacy and Safety of Oral Alitretinoin (Toctino®) in the Treatment of Patients With Cutaneous Lupus Erythema
NCT01407679
University Hospital MuensterPhase 2
CompletedEfficacy and Safety of Fumaric Acid Esters (Fumaderm®) in the Treatment of Patients With Cutaneous Lupus Eryth
NCT01352988
University Hospital MuensterPhase 2
CompletedA Study of the Safety and Pharmacokinetics of CNTO 136 in Patients With Cutaneous Lupus Erythematosus and Syst
NCT01702740
Centocor Research & Development, Inc.Phase 1
UnknownEuropean Society of Cutaneous Lupus Erythematosus (EUSCLE)
NCT00420121
European Society of Cutaneous Lupus Erythematosus e.V.—
CompletedPhase Ib Study of SC Milatuzumab in SLE
NCT01845740
Gilead SciencesPhase 1
WithdrawnCutaneous Lupus Erythematosus and Elidel
NCT00222183
University of LeipzigN/A